Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s558923 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Huike Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Chinese Medicine, Beijing, 100010, People's Republ…. Hauptthemen laut MEDLINE: Perylene, Photochemotherapy, Photosensitizing Agents, Skin Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Chinese Medicine, Beijing, 100010, People's Republic of China.
ORCID-Profile: Jingxia Zhao
Zitieren
APA
Ma, H., Zhang, X., Li, R., Qu, B., Liu, Y., Cui, Y., Zhang, T., & Zhao, J. (2026). Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s558923
Vancouver
Ma H, Zhang X, Li R, Qu B, Liu Y, Cui Y, et al. Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s558923
BibTeX
@article{Ma2026,
author = {Ma, Huike and Zhang, Xiawei and Li, Ruonan and Qu, Baoquan and Liu, Yuchen and Cui, Yunran and Zhang, Tianlu and Zhao, Jingxia},
title = {Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s558923}
}
EUVIMED